10 October 2020 : Clinical Research
miR-106a Targets Anoctamin 1 (ANO1) to Regulate Lipopolysaccharide (LPS)-Induced Inflammatory Response in Macrophages
Junfeng Heng1CDEF, Dingye Wu2BCD, Shiqi Lu1CDE*, Yiming Zhao2ABCDDOI: 10.12659/MSM.922479
Med Sci Monit 2020; 26:e922479

Figure 5 Overexpression of miR-106a attenuates anoctamin 1 (ANO1)-mediated inflammatory inhibition in lipopolysaccharide (LPS)-treated RAW264.7 cells. (A, B) Messenger ribonucleic acid (mRNA) and protein levels of ANO1 were measured in cells with transfection of pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic. (C, D) mRNA levels of interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) were measured in LPS-treated RAW264.7 cells transfected with pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic via quantitative real-time polymerase chain reaction. (E, F) Secretion levels of IL-6 and TNF-α were detected in cells transfected with pcDNA, ANO1 overexpression vector, ANO1 overexpression vector+miR-NC, or miR-106a mimic by enzyme-linked immunosorbent assay. * P<0.05.